热门资讯> 正文
Celsion更名为Imunon(IMNN)
2022-09-20 04:43
- Celsion (NASDAQ:CLSN) announced Monday its decision to change company's name to Imunon.
- The new name of clinical-stage drug development company is claimed to outline the "evolution of its business and its commitment to developing cutting-edge immunotherapies and next-generation vaccines to treat cancer and infectious diseases."
- Stock will begin trading under the new ticker symbol "IMNN", effective Sept 21, 2022.
- "With a strong balance sheet supporting current operations into 2025, we are well positioned to build a differentiated company to deliver on the promise of our gene-based therapies," commented Dr. Corinne Le Goff, president and CEO of Imunon.
- Earlier: Celsion says additional data shows placcine vaccine works against COVID-19 in animal model
推荐文章
飙涨60%创新高！英诺赛科官宣成英伟达供应商，机构喊话股价上行潜力仍然巨大
华盛早报丨黑天鹅来袭？特朗普掀起人事震动，美国对等关税生效在即；小米汽车7月交付量超3万辆
港股周报丨中美经贸会谈达成延长90天共识；京东、阿里、美团集体发文抵制外卖行业内卷
一周财经日历 | 特朗普对等关税将于8月7日生效；Palantir、超微电脑等财报来袭
8月金股抢先睇！港股能否继续抽升？哪些赛道值得关注
英诺赛科午前飙升逾31% 英伟达最新800V架构供应商名单曝光公司为中国唯一入选芯片企业
苹果第三财季营收940.36亿美元 净利润同比增长9%
外盘头条：白宫称特朗普将在午夜前设定新关税 苹果季度营收远超预期 Pimco青睐短至中期欧洲债券
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
